Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
17.5%
% of HRTS's 41 holdings also in OZEM
33.3%
% of OZEM's 22 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.9% | 16.9% | 10.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 2.3% | 4.7% | 2.3% |
|
REGENERON PHARMACEUTICALS | 1.9% | 2.3% | 1.9% |
|
GILEAD SCIENCES INC | 3.1% | 1.8% | 1.8% |
|
AMGEN INC | 1.7% | 3.0% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 5.6% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
|
ABBOTT LABORATORIES | 4.0% |
 |
ASTRAZENECA PLC | 4.0% |
 |
NOVO NORDISK A/S-B | 3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
NOVARTIS AG | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
 |
MEDTRONIC PLC | 3.0% |
HRTS Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -16.2% |
|
ELI LILLY & CO | -6.0% |
|
ROCHE HOLDING LTD | -4.9% |
|
ZEALAND PHARMA A/S | -3.8% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
|
PFIZER INC | -3.5% |
|
VIKING THERAPEUTICS, INC. | -3.3% |
 |
HANMI PHARM CO LTD | -3.1% |
|
ASTRAZENECA PLC-SPONS ADR | -3.1% |